An executive roundtable convened senior representatives from over 30 organizations, including development partners, regional organizations, and financing institutions, to examine financing across the diagnostics value chain. Discussions highlighted that diagnostics for LMICs remain underfunded and constrained by fragmented financing and gaps in critical evidence, particularly on development costs, market size, demand, and health and economic impact, and identified priority actions to strengthen the investment case, improve cost data, and better coordinate financing to accelerate impact.